James Wheeler, MD, PhD, is a board certified radiation oncologist who serves at Goshen Center for Cancer Care. He treats adult patients who have all kinds of cancer with all of the major, state-of-the-art forms of treatment, including image-guided radiation therapy, intensity modulated radiation therapy, high-dose rate brachytherapy, intra-operative radiation therapy, stereotactic radiotherapy and respiratory gated treatment, as well as more conventional forms of radiation treatment. Dr. Wheeler has extensive experience in the latest techniques for treating cancer, and is supportive of treating patients on clinical trials.
Philosophy of Care
For curable patients, Dr. Wheeler’s goal is to deliver an effective dose of radiation to eradicate the tumor while protecting the normal organs as much as possible. For patients who cannot be cured but are suffering from the effects of cancer, his goal is to relieve the symptoms caused by the cancer with minimal side effects from the radiation treatments. He notes that many cancers can be treated with fewer treatment sessions today than they could even a few years ago, with less patient inconvenience and fewer negative side effects
Dr. Wheeler treats patients with all types and stages of cancer. The most common cancers are breast cancer, prostate cancer, lung cancer and rectal cancer, but he also treats patients with uncommon or even very rare malignancies. He frequently uses intensity modulated radiation therapy to help decrease the side effects and increase the cure rates from radiation therapy. He is also a member of the American Brachytherapy Society, and is skilled at treating patients with radiation delivered from inside the body using various devices. Dr. Wheeler’s expertise also includes PET/ CT directed radiation therapy, stereotactic radiosurgery, stereotactic body radiation therapy and brachytherapy.
Dr. Wheeler has published papers in peer-reviewed journals regarding normal structure contouring (which is essential for accurate radiation therapy planning and delivery), head and neck cancer treatment and efforts to reduce side effects, early stage breast cancer, hormone refractory prostate cancer and how to determine if too many patients are experiencing complications soon after introducing a new treatment. He has been the principal investigator in a wide variety of clinical trials.